BioNxt Solutions Inc. BioNxt Solutions Inc.

BioNxt Solutions Inc.

BNXT

Rank in Stocks #25306
Headquartered in Vancouver, Canada, BioNxt Solutions Inc., established in 2017,... Headquartered in Vancouver, Canada, BioNxt Solutions Inc., established in 2017, operates as a bioscience company across Germany, Switzerland, Austria, Israel, and its home country. The firm focuses on developing innovative drug delivery systems, including transdermal patches and oral dissolvable films, specifically for neurological medications. It also advances psychedelic medicine applications to treat various mental health conditions such as depression, anxiety, addiction, and trauma-related stress disorder. Furthermore, BioNxt is engaged in creating point-of-care diagnostics, comprising rapid tests and biosensor screening tools, aimed at early disease detection, improved treatment efficacy, and enhanced disease management. This diagnostic portfolio features a COVID-19 PCR kit, alongside oral biosensors for peri-implantitis, H1N1 (swine flu), and H5N1 (avian flu). Complementing its development efforts, the company provides analytical testing and consulting services, and is involved in pathogen and oral health diagnostics, thin film drug formulation, and the production and formulation of psychedelic pharmaceuticals. The company adopted its current name in November 2022, having previously been known as XPhyto Therapeutics Corp.
Share Price
$0.20182135
Last synced: 2026-11-10
Market Cap
$26.23M
Change (1 day)
9.62%
Change (1 year)
-60.60%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for BioNxt Solutions Inc. (BNXT)
Operating Margin as of November 2026 TTM: 0.00%
According to BioNxt Solutions Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for BioNxt Solutions Inc. from 2017 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 0.00% 0.00%
2025 0.00% -100.00%
2024 -16,487.95% 863.92%
2023 -1,710.51% -15.83%
2022 -2,032.30% -64.30%
2021 -5,692.90% 31.43%
2020 -4,331.55% 25.83%
2019 -3,442.43% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
19.69% -
DE
19.68% -
DE
13.26% -
JP
17.08% -
CH
10.53% -
IL
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about BioNxt Solutions Inc.'s operating margin

What was BioNxt Solutions Inc.'s operating margin in 2025?

In 2025, BioNxt Solutions Inc.'s operating margin was 0.00%, compared with -16,487.95% in 2024.

How has BioNxt Solutions Inc.'s operating margin changed since 2020?

From 2020 to 2025, BioNxt Solutions Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2024 (-16,487.95%).

How does BioNxt Solutions Inc.'s operating margin compare with similar companies?

BioNxt Solutions Inc.'s operating margin (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with 19.69%.